Skip to main content

Table 1 Patient characteristics

From: Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy

Variables

Age -- years

   Median

   55

   Range

   22-78

FIGO stage -- No. (%)

   IB

   11 ( 9.8)

   IIA

   13 (11.6)

   IIB

   66 (58.9)

   III/IV

   22 (19.7)

Histology -- No. (%)

   Squamous cell carcinoma

   102 (91.1)

   Adenocarcinoma

   7 ( 6.2)

   Adenosquamous cell carcinoma

   3 ( 2.7)

Pelvic lymph node* -- No. (%)

   Positive

   61 (54.5)

   Negative

   51 (45.5)

Tumor diameter -- No. (%)

   Range (cm)

   1-10

   ≤4 cm

   65 (58.0)

   >4 cm

   47 (42.0)

  1. Abbreviations: FIGO = International Federation of Gynecology and Obstetrics.
  2. * Pelvic lymph node status was diagnosed by imaging study.